ASF Research Grants
ASF Research Grants from the Angelman Syndrome Foundation fund innovative research to advance understanding and treatment of Angelman syndrome, focusing on key scientific priorities.
Funder: Angelman Syndrome Foundation
Due Dates: September 1, 2026 (Annual proposal submission deadline)
Funding Amounts: Up to $100,000 per year | 1- or 2-year grants | 10% indirect costs allowed (included in total)
Summary: Supports innovative research advancing understanding and treatment of Angelman syndrome, with priority to projects aligned with ASF’s strategic scientific roadmap.
Key Information: Open to global researchers; proposals must align with ASF’s research priorities; awarded to institutions, not individuals.
Description
The Angelman Syndrome Foundation (ASF) offers annual research grants to support pioneering scientific studies that further the understanding, treatment, and clinical care of Angelman syndrome (AS). The program is guided by the ASF 2025 Research Roadmap, which emphasizes four strategic pillars: UBE3A regulation and function, next-generation therapeutic strategies, clinical care innovations, and the development of new therapeutic endpoints and biomarkers. ASF’s mission is to accelerate the development of effective treatments and improve quality of life for individuals with AS by funding high-impact, collaborative research from scientists and clinicians worldwide.
